Antifungal efficacy of ten selected South African plant species against Cryptococcus neoformans

23Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Fungal infections are a major threat to public health care. Cryptococcosis in humans and animals, caused by Cryptococcus neoformans, is a life-threatening disease. In a random antifungal screening of acetone leaf extracts of 400 tree species against Cryptococcus neoformans, the following plant species had good activity: Zanthoxylum capense (Thunb.) Harv. (Rutaceae), Morusmesozygia Stapf (Moraceae), Calodendrum capense (L.f.) Thunb. (Rutaceae), Catha transvaalensis Codd (Celastraceae), Cussonia zuluensis Strey (Araliaceae), Ochna natalitia (Meisn.) Walp. (Ochnaceae), Croton sylvaticus Hochst. ex C. Krauss (Euphorbiaceae), Maytenus undata (Thunb.) Blakelock (Celastraceae), Celtis africana Burm.f. (Ulmaceae), and Cassine aethiopica Thunb. (Celastraceae). Hexane, dichloromethane, acetone, and methanol extracts of these 10 plants were tested against Cryptococcus neoformans using bioautography and microdilution assays. Acetone extracted the highest quantity of plant material. Dichloromethane and hexane extracts of Maytenus undata showed clear bands in bioautography while the other species did not produce good results in bioautography. Maytenus undata extracts had promising antifungal activity against C. neoformans, with average minimum inhibitory concentration (MIC) of 0.09mg/mL after 24h and 0.18mg/mL after 48h incubation. Croton sylvaticus and Catha transvaalensis extracts also had good activity, with average MIC values of 0.07mg/mL and 0.09mg/mL, respectively. Because of the clear bands on bioautograms and low MIC values compared to the other plant species investigated, M. undata was identified as a good candidate for further studies.

Cite

CITATION STYLE

APA

Mokoka, T. A., McGaw, L. J., & Eloff, J. N. (2010). Antifungal efficacy of ten selected South African plant species against Cryptococcus neoformans. Pharmaceutical Biology, 48(4), 397–404. https://doi.org/10.3109/13880200903150393

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free